Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25171568.
- Also identified by DOI 10.1097/BPB.0000000000000098.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to assess the effects of botulinum on spasticity of gastrocnemius and soleus muscles. Forty-one children with spastic cerebral palsy were assessed (muscle tone, range of motion of ankle joint extension with straightened and bent knee, and gait pattern using the Physician Rating Scale) before administration and 2, 6, and 13 weeks after. Changes on Physician Rating Scale and dorsiflexion with extended knee were significant after 2, 6, and 13 weeks. Differences in the remaining parameters were significant after the first two check-ups. Over 90% of the changes were positive. This research confirms the effectiveness of botulinum in reducing spasticity, increasing the range of motion, and improving the gait pattern.
Medical subject headings
- Ankle Joint
- Botulinum Toxins, Type A
- Cerebral Palsy
- Muscle Spasticity
- Muscle, Skeletal
- Neuromuscular Agents
Anatomy
- ankle